superficiale Credenza Limitato short acting muscarinic antagonist appassionato avanzi Bandito
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Bronchodilators: Beta 2-agonists and muscarinic antagonists | Osmosis
New developments in inhaled therapy | Practice Nursing
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Introduction - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Mechanisms of action of LAMAs. ACh, acetylcholine; LAMA, longacting... | Download Scientific Diagram
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
An additional effect of short-acting muscarinic antagonists plus... | Download Scientific Diagram
Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD | European Respiratory Society
A randomized controlled trial of long-acting muscarinic antagonist and long- acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease | BMC Pulmonary Medicine | Full Text
Inhaled bronchodilators for chronic bronchitis and emphysema - Document - Gale Academic OneFile
Practical considerations when prescribing a long-acting muscarinic ant | COPD
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis - Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai, Jian Liu, 2021
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
Natalies Casebook | Tag
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Long-Acting Muscarinic Antagonists Under Investigational to Treat Chro | JEP
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library